Diabetic Eye Exam

Diabetes is one of the top ten most prevalent and important non-infectious causes of morbidity and mortality worldwide. An estimated 34.1 million Americans aged 18 years or older, 13.0% of all U.S. adults, had diabetes in 2018.

Diabetic retinopathy represents microvascular end-organ damage as a result of diabetes. It ranges from non-proliferative diabetic retinopathy (NPDR) and its stages to proliferative diabetic retinopathy (PDR). As the disease progresses, associated diabetic macular edema may also become apparent.

Among patients aged 25-74, diabetic retinopathy is a leading cause of vision loss worldwide. By 2030 an estimated 191.0 million people globally will have diabetic retinopathy, and approximately 56.3 million will have vision-threatening diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) Cohort showed that after 20 years of diabetes mellitus, 99% of patients with type 1 and 60% of patients with type 2 show some degree of retinopathy. There are several other key risk factors for the development of diabetic retinopathy beyond years since diagnosis and type of diabetes. Additionally, elevated hemoglobin A1c (HbA1c) levels and blood pressure are associated with increased risk of diabetic retinopathy.

Diagnosis

Our facility is equipped with the latest technology to provide a comprehensive evaluation of your eyes and your retina to pick those early changes of diabetes in retina.

Treatment

Your doctor will plan for you and provide you with a careful plan to manage your diabetic eye disease.